Literature DB >> 30483447

Glycoproteins isolated from Atractylodes macrocephala Koidz improve protective immune response induction in a mouse model.

Kyoung-A Kim1, Young-Ok Son2, So-Soon Kim3, Yong-Suk Jang3, Young-Hyun Baek1, Chun-Chu Kim1, Jeong-Hoon Lee1, Jeong-Chae Lee1,3.   

Abstract

This study examined the efficacy of Atractylodes macrocephala Koidz (AMK) protein and polysaccharide extracts as adjuvant or adjuvant booster when given together with porcine pleuropneumonia vaccine. Experimental mice (n = 5/group) were subcutaneously immunized with 25 μg ApxIIA #3 antigen, a target protein against A. pleuropneumoniae, together with alum and/or various concentrations (0-500 μg) of the AMK extracts, while the control group received PBS only. Immunization with ApxIIA #3 antigen increased the antigen-specific IgG titer and this increase was enhanced in the immunization together with AMK protein, but not polysaccharide extract. Supplementation of AMK protein extract exhibited dose-dependent increases in the antigen-induced protective immunity against A. pleuropneumoniae challenge and in the lymphocyte proliferation specific to the antigen. Glycoproteins present in the AMK extract were the active components responsible for immune response induction. Collectively, the present findings suggest that AMK glycoproteins are useful as immune stimulating adjuvant or adjuvant booster.

Entities:  

Keywords:  Adjuvant; ApxII toxin; Glycoproteins; Immunoglobulin; Oriental traditional medicine

Year:  2018        PMID: 30483447      PMCID: PMC6233402          DOI: 10.1007/s10068-018-0430-1

Source DB:  PubMed          Journal:  Food Sci Biotechnol        ISSN: 1226-7708            Impact factor:   2.391


  20 in total

1.  What are the limits of adjuvanticity?

Authors:  G Del Giudice; A Podda; R Rappuoli
Journal:  Vaccine       Date:  2001-10-15       Impact factor: 3.641

Review 2.  Mucosal immunity and vaccines.

Authors:  Jan Holmgren; Cecil Czerkinsky
Journal:  Nat Med       Date:  2005-04       Impact factor: 53.440

3.  Stimulating effects on mouse splenocytes of glycoproteins from the herbal medicine Atractylodes macrocephala Koidz.

Authors:  J-C Lee; K-Y Lee; Y-O Son; K-C Choi; J Kim; S-H Kim; G-H Chung; Y-S Jang
Journal:  Phytomedicine       Date:  2006-11-03       Impact factor: 5.340

4.  Macrophage activation by polysaccharides from Atractylodes macrocephala Koidz through the nuclear factor-κB pathway.

Authors:  Guang-Quan Ji; Ren-Qiong Chen; Jian-Xian Zheng
Journal:  Pharm Biol       Date:  2014-10-20       Impact factor: 3.503

5.  Polysaccharides from Ganoderma formosanum function as a Th1 adjuvant and stimulate cytotoxic T cell response in vivo.

Authors:  Chia-Chen Pi; Ching-Liang Chu; Chu-Ying Lu; Yu-Jing Zhuang; Cheng-Li Wang; Yao-Hsuan Yu; Hui-Yi Wang; Chih-Chung Lin; Chun-Jen Chen
Journal:  Vaccine       Date:  2013-11-17       Impact factor: 3.641

6.  Characterization of antigenic determinants in ApxIIA exotoxin capable of inducing protective immunity to Actinobacillus pleuropneumoniae challenge.

Authors:  Ki-Weon Seo; Dong-Heon Kim; Ah Hyun Kim; Han-Sang Yoo; Kyung-Yeol Lee; Yong-Suk Jang
Journal:  Immunol Invest       Date:  2011-03-22       Impact factor: 3.657

7.  Nasal immunization with major epitope-containing ApxIIA toxin fragment induces protective immunity against challenge infection with Actinobacillus pleuropneumoniae in a murine model.

Authors:  Ki-Weon Seo; Sae-Hae Kim; Jisang Park; Youngok Son; Han Sang Yoo; Kyung-Yeol Lee; Yong-Suk Jang
Journal:  Vet Immunol Immunopathol       Date:  2012-11-09       Impact factor: 2.046

Review 8.  MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile.

Authors:  Audino Podda; Giuseppe Del Giudice
Journal:  Expert Rev Vaccines       Date:  2003-04       Impact factor: 5.217

9.  Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59.

Authors:  G Ott; G L Barchfeld; G Van Nest
Journal:  Vaccine       Date:  1995-11       Impact factor: 3.641

Review 10.  Vaccination strategies to promote mucosal antibody responses.

Authors:  Kang Chen; Andrea Cerutti
Journal:  Immunity       Date:  2010-10-29       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.